Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Verdonck

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Leukemia & Lymphoma|June 1, 1999
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: updated results of the Utrecht experienceL F Verdonck
Leukemia Research|January 1, 1997
Ether lipids are effective cytotoxic drugs against multidrug-resistant acute leukemia cells and can act by the induction of apoptosisL F Verdonck, H G van Heugten
Lancet (London, England)|April 28, 1984
Is cytomegalovirus infection a major cause of T cell alterations after (autologous) bone-marrow transplantation?L F Verdonck, G C de Gast
Nederlands Tijdschrift Voor Geneeskunde|December 13, 2003
[Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands]E J Petersen, H L Lokhorst, L F Verdonck
Cancer|May 1, 1990
Intermediate-dose cytosine arabinoside and amsacrine. An effective regimen with low toxicity in refractory acute nonlymphocytic leukemiaA W Dekker, H K Nieuwenhuis, L F Verdonck
Cancer|September 1, 1987
Successful treatment with chemotherapy and subsequent allogeneic bone marrow transplantation for myeloid blastic crisis of chronic myelogenous leukemia following advanced Hodgkin's diseaseC J Punt, M Rozenberg-Arska, L F Verdonck
Bone Marrow Transplantation|July 1, 1994
Infection prevention in autologous bone marrow transplantation and the role of protective isolationA W Dekker, L F Verdonck, M Rozenberg-Arska
Blood|October 1, 1985
Delay in platelet recovery after bone marrow transplantation: impact of cytomegalovirus infectionL F Verdonck, H van Heugten, G C de Gast
Leukemia & Lymphoma|June 28, 2001
Prevention of acute graft-versus-host-disease by selective depletion of T cells reactive with minor histocompatibility antigens on epithelial cellsH G Otten, A M Van Dyk, L F Verdonck
Experimental Hematology|September 1, 1985
Cytotoxic T-cell capacity after autologous bone marrow transplantationG C de Gast, L F Verdonck, H A Kreeft
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|June 1, 1999
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: updated results of the Utrecht experienceL F Verdonck
Leukemia Research|January 1, 1997
Ether lipids are effective cytotoxic drugs against multidrug-resistant acute leukemia cells and can act by the induction of apoptosisL F Verdonck, H G van Heugten
Lancet (London, England)|April 28, 1984
Is cytomegalovirus infection a major cause of T cell alterations after (autologous) bone-marrow transplantation?L F Verdonck, G C de Gast
Nederlands Tijdschrift Voor Geneeskunde|December 13, 2003
[Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands]E J Petersen, H L Lokhorst, L F Verdonck
Cancer|May 1, 1990
Intermediate-dose cytosine arabinoside and amsacrine. An effective regimen with low toxicity in refractory acute nonlymphocytic leukemiaA W Dekker, H K Nieuwenhuis, L F Verdonck
Cancer|September 1, 1987
Successful treatment with chemotherapy and subsequent allogeneic bone marrow transplantation for myeloid blastic crisis of chronic myelogenous leukemia following advanced Hodgkin's diseaseC J Punt, M Rozenberg-Arska, L F Verdonck
Bone Marrow Transplantation|July 1, 1994
Infection prevention in autologous bone marrow transplantation and the role of protective isolationA W Dekker, L F Verdonck, M Rozenberg-Arska
Blood|October 1, 1985
Delay in platelet recovery after bone marrow transplantation: impact of cytomegalovirus infectionL F Verdonck, H van Heugten, G C de Gast
Leukemia & Lymphoma|June 28, 2001
Prevention of acute graft-versus-host-disease by selective depletion of T cells reactive with minor histocompatibility antigens on epithelial cellsH G Otten, A M Van Dyk, L F Verdonck
Experimental Hematology|September 1, 1985
Cytotoxic T-cell capacity after autologous bone marrow transplantationG C de Gast, L F Verdonck, H A Kreeft
Pageof 13